The therapeutic effects of human adipose-derived stem cells in alzheimer's disease mouse models

Neurodegenerative Diseases

Volumn 13, Issue 2-3, 2014, Pages 99-102

  Chang, Keun A ^a   Kim, Hee Jin ^b,c   Joo, Yuyoung ^a   Ha, Sungji ^a   Suh, Yoo Hun ^b,c  

^a Gachon University   (South Korea)

^b Seoul National University   (South Korea)

^c Korea Brain Research Institute (KBRI)   (South Korea)

Author keywords

Adipose derived stem cells; Alzheimer's disease

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 10; VASCULOTROPIN;

ADIPOSE DERIVED STEM CELL; ALZHEIMER DISEASE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL THERAPY; CYTOKINE RELEASE; HUMAN; INTRAVENOUS ADMINISTRATION; MESENCHYMAL STEM CELL; NERVE CELL DIFFERENTIATION; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; THERAPY EFFECT; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; HUMAN CELL; MEMORY DISORDER; MOUSE; NEUROPATHOLOGY; STEM CELL TRANSPLANTATION; TG2576 MOUSE;

ADIPOSE TISSUE; ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; PLURIPOTENT STEM CELLS;

EID: 84896732245     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000355261     Document Type: Article

References (23)

1. Tohill M, Terenghi G: Stem-cell plasticity and therapy for injuries of the peripheral nervous system. Biotechnol Appl Biochem 2004; 40: 17-24.
2. Zuk PA, Zhu M, Ashjian P, et al: Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279-4295.
3. Grewal NS, Gabbay JS, Ashley RK, Wasson KL, Bradley JP, Zuk PA: BMP-2 does not influence the osteogenic fate of human adiposederived stem cells. Plast Reconstr Surg 2009; 123: 158S-165S.
4. Tomita K, Madura T, Sakai Y, Yano K, Terenghi G, Hosokawa K: Glial differentiation of human adipose-derived stem cells: implications for cell-based transplantation therapy. Neuroscience 2013; 236: 55-65.
5. Ra JC, Shin IS, Kim SH, et al: Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev 2011; 20: 1297-1308.
6. Lee ST, Chu K, Jung KH, et al: Slowed progression in models of Huntington disease by adipose stem cell transplantation. Ann Neurol 2009; 66: 671-681.
7. Bhang SH, Cho SW, Lim JM, et al: Locally delivered growth factor enhances the angiogenic efficacy of adipose-derived stromal cells transplanted to ischemic limbs. Stem Cells 2009; 27: 1976-1986.
8. Im W, Ban J, Lim J, et al: Extracts of adipose derived stem cells slows progression in the R6/2 model of Huntington's disease. PLoS One 2013; 8:e59438.
9. Kim S, Chang KA, Kim J, et al: The preventive and therapeutic effects of intravenous human adipose-derived stem cells in Alzheimer's disease mice. PLoS One 2012; 7:e45757.
10. Lin MN, Shang DS, Sun W, et al: Involvement of PI3K and ROCK signaling pathways in migration of bone marrow-derived mesenchymal stem cells through human brain microvascular endothelial cell monolayers. Brain Res 2013; 1513: 1-8.
11. Blurton-Jones M, Kitazawa M, Martinez-Coria H, et al: Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci USA 2009; 106: 13594-13599.
12. Lee HJ, Lee JK, Lee H, et al: The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease. Neurosci Lett 2010; 481: 30-35.
13. Lee JK, Jin HK, Endo S, Schuchman EH, Carter JE, Bae JS: Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells 2010; 28: 329-343.
14. Katsuda T, Tsuchiya R, Kosaka N, et al: Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysinbound exosomes. Sci Rep 2013; 3: 1197.
15. Yamasaki TR, Blurton-Jones M, Morrissette DA, Kitazawa M, Oddo S, LaFerla FM: Neural stem cells improve memory in an inducible mouse model of neuronal loss. J Neurosci 2007; 27: 11925-11933.
16. Martino G, Pluchino S: The therapeutic potential of neural stem cells. Nat Rev Neurosci 2006; 7: 395-406.
17. Bao X, Wei J, Feng M, et al: Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Res 2011; 1367: 103-113.
18. Liu N, Chen R, Du H, Wang J, Zhang Y, Wen J: Expression of IL-10 and TNF-alpha in rats with cerebral infarction after transplantation with mesenchymal stem cells. Cell Mol Immunol 2009; 6: 207-213.
19. Mathieu P, Battista D, Depino A, Roca V, Graciarena M, Pitossi F: The more you have, the less you get: the functional role of inflammation on neuronal differentiation of endogenous and transplanted neural stem cells in the adult brain. J Neurochem 2010; 112: 1368-1385.
20. Carpentier PA, Palmer TD: Immune influence on adult neural stem cell regulation and function. Neuron 2009; 64: 79-92.
21. Ruiz de Almodovar C, Lambrechts D, Mazzone M, Carmeliet P: Role and therapeutic potential of VEGF in the nervous system. Physiol Rev 2009; 89: 607-648.
22. Kalbermatten DF, Schaakxs D, Kingham PJ, Wiberg M: Neurotrophic activity of human adipose stem cells isolated from deep and superficial layers of abdominal fat. Cell Tissue Res 2011; 344: 251-260.
23. Rehman J, Traktuev D, Li J, et al: Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004; 109: 1292-1298.